Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy
- 31 January 1996
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 17 (1), 39-45
- https://doi.org/10.1016/0167-5699(96)80567-6
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- The Impact of Gene Therapy on T Cell Function in CancerHuman Gene Therapy, 1995
- The regulation and function of p21ras during T-cell activation and growthImmunology Today, 1995
- Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicityCurrent Opinion in Oncology, 1994
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cellsCancer Immunology, Immunotherapy, 1993
- Cancer vaccinesImmunology Today, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991